Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan

Acta Pharmaceutica Sinica B

Volumn 2, Issue 5, 2012, Pages 502-508

  Chella, Naveen ^a,c   Shastri, Nalini ^a   Tadikonda, Rama Rao ^b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b Blue Birds College of Pharmacy   (India)

^c ACHARYA NAGARJUNA UNIVERSITY   (India)

Author keywords

Dissolution; Liquisolid compact; Poorly soluble drug; Valsartan

Indexed keywords

VALSARTAN;

ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PH; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; X RAY POWDER DIFFRACTION;

EID: 84886736215     PISSN: 22113835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apsb.2012.07.005     Document Type: Article

References (25)

1. Wong S.M., Kellaway I.W., Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 2006, 317:61-68.
2. Hörter D., Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001, 46:75-87.
3. Water insoluble drug formulation 2008, CRC press, New York. 2nd ed. R. Liu (Ed.).
4. Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971, 60:1281-1302.
5. Blagden N., de Matas M., Gavan P., York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007, 59:617-630.
6. Sonoda R., Horibe M., Oshima T., Iwasaki T., Watano S. Improvement of dissolution property of poorly water-soluble drug by novel dry coating method using planetary ball mill. Chem Pharm Bull 2008, 56:1243-1247.
7. Jin X., Zhang Z., Sun E., Li S., Jia X. Statistically designed enzymatic hydrolysis of an icariin/Β-cyclodextrin inclusion complex optimized for production of icaritin. Acta Pharma Sin B 2012, 2:83-89.
8. Gursoy R.N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004, 58:173-182.
9. Ahuja G., Pathak K. Porous carriers for controlled or modulated delivery. Indian J Pharm Sci 2009, 71:599-607.
10. Spireas S, Bolton SM, inventors. Liquisolid systems and method of preparing same. United States patent US 6096337. 2000 August 1.
11. Tiong N., Elkordy A.A. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm 2009, 73:373-384.
12. Javadzadeh Y., Jafari-Navimipour B., Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm 2007, 341:26-34.
13. Gubbi S.R., Jarag R. Formulation and characterization of atorvastatin calcium liquisolid compacts. Asian J Pharma Sci 2010, 5:50-60.
14. Karmarkar A.B., Gonjari I.D., Hosmani A.H., Dhabale P.N., Bhise S.B. Dissolution rate enhancement of fenofibrate using liquisolid tablet technique. Lat Am J Pharm 2009, 28:219-225.
15. Ahad A., Aqil M., Kohli K., Sultana Y., Mujeeb M., Ali A. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm 2011, 37:583-596.
16. Kshirsagar S.J., Bhalekar M.R., Madgulkar A.R., Sable P.N, Gupta S.R. Dissolution improvement of poorly water soluble drug valsartan and improving flow properties of solid dispersion. Lat Am J Pharm 2010, 29:393-400.
17. Ibrahim H.K., El-Setouhy D.A. Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization. AAPS PharmSciTech 2010, 11:189-196.
18. Dixit A.R., Rajput S.J., Patel S.G. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 2010, 11:314-321.
19. Raja R.K., Abbulu K., Sudhakar M. Development, characterization and solubility study of solid dispersion of valsartan. J Chem Pharm Res 2011, 3:180-187.
20. Friedrich H., Fussnegger B., Kolter K., Bodmeier R. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm 2006, 62:171-177.
21. Spireas S., Wang T., Grover R. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm 1999, 25:163-168.
22. Fahmy R., Kassem M. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2008, 69:993-1003.
23. Banker G.S., Anderson N.R. Tablets. The theory and practice of industrial pharmacy 2009, CBS Publishers, New Delhi, p. 293-345. L. Lachman, H.A. Lieberman (Eds.).
24. Javadzadeh Y., Rezasiahi M.D., Asnaashari S., Nokhodchi A. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharm 2007, 57:99-109.
25. Griesser U.J., Stowell J.G. Solid state analysis and polymorphism. Pharmaceutical analysis 2008, Blackwell publishing, Oxford, p. 240-294. D.C. Lee, M.L. Webb (Eds.).